Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: Implications for assessment of therapeutic interventions in Hurler syndrome

被引:40
作者
Braunlin, E
Mackey-Bojack, S
Panoskaltsis-Mortari, A
Berry, JM
McElmurry, RT
Riddle, M
Sun, LY
Clarke, LA
Tolar, J
Blazar, BR
机构
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] Jesse E Edwards Cardiovasc Registry, St Paul, MN 55102 USA
[3] Univ British Columbia, Dept Genet, Vancouver, BC V5Z 4H4, Canada
关键词
D O I
10.1203/01.pdr.0000190579.24054.39
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hurler syndrome (mucopolysaccharidosis type I [MPS I]) is a uniformly lethal autosomal recessive storage disease caused by absence of the enzyme alpha-L-iduronidase (IDUA), which is involved in lysosomal degradation of sulfated glycosaminoglycans (GAGs). Cardiomyopathy and valvar insufficiency occur as GAGs accumulate in the myocardium, spongiosa of cardiac valves, and myointima of coronary arteries. Here we report the functional, biochemical. and morphologic cardiac findings in the MPS I mouse. We compare the cardiac functional and histopathological findings in the mouse to human MPS I. In MPS I mice, we have noted aortic insufficiency, increased left ventricular size, and decreased ventricular function. Aortic and mitral valves are thickened and the aortic root is dilated. However, murine MPS I is not identical to human MPS I. Myointimal proliferation of epicardial coronary arteries is unique to human MPS I. whereas dilation of aortic root appears unique to murine MPS I. Despite the differences between murine and human MPS i, the murine model provides reliable in vivo outcome parameters, such as thickened and insufficient aortic valves and depressed cardiac function that can be followed to assess the impact of therapeutic interventions in preclinical studies in Hurler syndrome.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 26 条
  • [1] Beesley CE, 2001, HUM GENET, V109, P503
  • [2] Usefulness of bone marrow transplantation in the Hurler syndrome
    Braunlin, EA
    Stauffer, NR
    Peters, CH
    Bass, JL
    Berry, JM
    Hopwood, JJ
    Krivit, W
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (07) : 882 - 886
  • [3] CORONARY-ARTERY DISEASE IN THE HURLER SYNDROME - QUALITATIVE AND QUANTITATIVE-ANALYSIS OF THE EXTENT OF CORONARY NARROWING AT NECROPSY IN 6 CHILDREN
    BROSIUS, FC
    ROBERTS, WC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (03) : 649 - 653
  • [4] AORTIC ROOT DILATATION AND MITRAL-VALVE PROLAPSE IN MARFANS-SYNDROME - ECHOCARDIOGRAPHIC STUDY
    BROWN, OR
    DEMOTS, H
    KLOSTER, FE
    ROBERTS, A
    MENASHE, VD
    BEALS, RK
    [J]. CIRCULATION, 1975, 52 (04) : 651 - 657
  • [5] Murine mucopolysaccharidosis type I: Targeted disruption of the murine alpha-L-iduronidase gene
    Clarke, LA
    Russell, CS
    Pownall, S
    Warrington, CL
    Borowski, A
    Dimmick, JE
    Toone, J
    Jirik, FR
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (04) : 503 - 511
  • [6] Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders - clinical and echocardiographic findings in 64 patients
    Dangel, JH
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (07) : 534 - 538
  • [7] Mouse models of atherosclerosis
    Daugherty, A
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (01) : 3 - 10
  • [8] Di Domenico C, 2005, HUM GENE THER, V16, P81
  • [9] GLYCOSAMINOGLYCAN (GAG) DISTRIBUTION IN AORTIC WALL FROM 5 SPECIES
    GARDAIS, A
    PICARD, J
    HERMELIN, B
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY, 1973, 44 (2B): : 507 - &
  • [10] CARDIAC INVOLVEMENT IN MUCOPOLYSACCHARIDOSES - EFFECTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GATZOULIS, MA
    VELLODI, A
    REDINGTON, AN
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (03) : 259 - 260